# Effectiveness and Safety of Mitral Valve Repair With the NeoChord DS1000 Artificial Chordae Delivery System Versus Conventional Surgery in Patients With Severe Primary Mitral Regurgitation Due to Isolated Leaflet Prolapse

> **NCT02829749** · NA · WITHDRAWN · sponsor: **Hospices Civils de Lyon**

## Conditions studied

- Cardiovascular Diseases

## Interventions

- **DEVICE:** NeoChord beating heart mitral valve implantation
- **PROCEDURE:** Control

## Key facts

- **NCT ID:** NCT02829749
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-06
- **Primary completion:** 2022-10
- **Final completion:** 2022-10
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Because of dynamics in the field of minimal invasive mitral repair and the development of newer devices
- **Last updated:** 2020-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02829749

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02829749, "Effectiveness and Safety of Mitral Valve Repair With the NeoChord DS1000 Artificial Chordae Delivery System Versus Conventional Surgery in Patients With Severe Primary Mitral Regurgitation Due to Isolated Leaflet Prolapse". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02829749. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*